Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$1,489,787.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Veterans’ Health
154469
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$1,499,981.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Indigenous Peoples' Health
154461
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$1,495,716.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Neurodevelopment
154460
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$644,843.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Mental Health
154465
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$1,499,546.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Cardio-Respiratory/Sleep
154458
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$750,000.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Multiple Sclerosis
154468
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$1,150,000.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas
154456
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area.
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$1,499,915.00
Jan 1, 2020
Individual or sole proprietorship
Team Grant: Cannabis Research in Priority Areas - Neurodevelopment
154459
Generate new scientific knowledge that will advance our understanding of the potential benefits and/or harms of cannabis and/or cannabis use, and impact policies and programs in this area
Encourage interdisciplinary collaborations, including from across health research and from domains outside of health research, and the sharing of data and resources
Enhance capacity development and training in cannabis research
Connect to existing knowledge translation efforts across Canada, for example through the Mental Health Commission of Canada (MHCC) or the Canadian Centre on Substance Use and Addiction (CCSA)
$200,000.00
Jan 1, 2020
For-profit organization
Super: cannabis marketplace platform launch
943575
Project Summary
Mobile app build, web app build, frontend and backend compliance by market geo, POS integrations, payment processor integrations.
$400,000.00
Jan 1, 2020
For-profit organization
Development of Cannabis and Nutraceutical infused QuickStrip Products
935556
Rapid Dose Therapeutics Corp. (RDT) is a publicly traded Canadian life science company (CSE: DOSE) that develops innovative, proprietary drug delivery technologies designed to improve health and wellness outcomes and improve quality of life. Our QuickStrip™ product line is an oral dissolvable film strip infused with a precise dose of active medicinal ingredient that is rapidly transferred through the oral mucosa under the tongue (sublingual delivery) or inside the mouth (buccal delivery), enabling high bioavailability and fast drug onset time. Our plan is to expand and scale up our product innovation program over 2019-2021 to support the commercial development and scaleup manufacturing of new QuickStrip™ oral thin film products.